Celltrion | Biosimillar Products

Biosimilars

Biosimilars

Name INN More Information

NameRemsima®: INNInfliximab; More Information Product Information Consumer Medicine Information (CMI)
NameTruxima®: INNRituximab; More Information Product Information Consumer Medicine Information (CMI)
NameHerzuma®: INNTrastuzumab; More Information Product Information Consumer Medicine Information (CMI)
NameRemsima® SC: INNInfliximab; More Information Product Information Consumer Medicine Information (CMI) - Pre-filled Syringe Consumer Medicine Information (CMI) - Pre-filled Pen
NameYuflyma®: INNAdalimumab; More Information Product Information Consumer Medicine Information (CMI)
NameVegzelma®: INNBevacizumab; More Information Product Information Consumer Medicine Information (CMI)
NameOmlyclo®: INNOmalizumab; More Information Product Information Consumer Medicine Information (CMI)
NameSteqeyma®: INNUstekinumab; More Information Product Information Consumer Medicine Information (CMI)
NameStoboclo®: INNDenosumab; More Information Product Information Consumer Medicine Information (CMI)
NameOsenvelt®: INNDenosumab; More Information Product Information Consumer Medicine Information (CMI)
NameAvtozma®: INNTocilizumab; More Information Product Information Consumer Medicine Information (CMI)
NameEydenzelt®: INNAflibercept; More Information Product Information

Celltrion Healthcare Australia Pty Ltd is not able to provide any advice to patients. This product description is for medical and educational purposes only and not intended to promote the product.

For more details on the risks and benefits, please consult a doctor or healthcare professional.

For adverse events, product quality feedback or medical enquiries, please contact Celltrion Healthcare Australia by emailing medinfo-au@celltrionhc.com or calling 1800 325 228

※ INN, international non-proprietary name